{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T20:25:31Z","timestamp":1778185531793,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T00:00:00Z","timestamp":1605484800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T00:00:00Z","timestamp":1605484800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"crossref","award":["2017B020230003"],"award-info":[{"award-number":["2017B020230003"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Raised intracranial pressure (ICP) and insufficient antifungal regimens are the two main factors result to unsatisfactory outcomes in non-HIV cryptococcal meningitis (CM) patients. In this study, we try to discuss that whether triple therapy of amphotericin B (AmB), fluconazole, 5-flucytosine (5-FC) plus ventriculoperitoneal shunts (VPS) is superior to AmB, 5-FC, fluconazole plus intermittent lumbar puncture in induction therapy in non-HIV CM patients with increased ICP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We reviewed 66 clinical records from non-HIV CM patients with increased ICP. The demographic and clinical characteristics, BMRC staging, cerebrospinal fluid profiles (CSF), brain magnetic resonance imaging, treatment, and outcomes of these individuals were retrospectively analyzed. All non-HIV CM patients with increased ICP (\u2265 25 cmH2O) were divided into two groups, including 27 patients treated with triple antifungal agents and 39 patients treated with the same triple therapy plus VPS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Triple therapy plus VPS group had more satisfactory outcomes, more CSF sterilization at 10\u2009weeks follow-up, lower CSF opening pressure, lower BMRC staging scores one week after VPS, less CSF\n                      <jats:italic>C. neoformans<\/jats:italic>\n                      counts and CSF culture positive. Besides, these patients had shorter hospital stay than triple therapy group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Triple antifungal agents combined with VPS could effectively reduce ICP, had faster rate of clearance of\n                      <jats:italic>C. neoformans<\/jats:italic>\n                      counts, more improved neurological function, shorten hospitalization time and better outcomes in non-HIV CM patients with increased ICP. Our study indicated that triple therapy plus early VPS may be an optimal treatment for non-HIV CM patients with increased ICP.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-020-05510-9","type":"journal-article","created":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T05:06:22Z","timestamp":1605503182000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Triple therapy combined with ventriculoperitoneal shunts can improve neurological function and shorten hospitalization time in non-HIV cryptococcal meningitis patients with increased intracranial pressure"],"prefix":"10.1186","volume":"20","author":[{"given":"Min","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuhui","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingzhou","family":"Gan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yijie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuhua","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,16]]},"reference":[{"key":"5510_CR1","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","volume":"17","author":"R Rajasingham","year":"2017","unstructured":"Rajasingham R, Smith RM, Park BJ, Jarvis JN, Govender NP, Govender NP, Chiller TM, Denning DW, Loyse A, Boulware DR. Global burden of disease of HIV-associated cryptococcal meningitis an updated analysis. Lancet Infect Dis. 2017;17:873\u201381. https:\/\/doi.org\/10.1016\/S1473-3099(17)30243-8.","journal-title":"Lancet Infect Dis"},{"key":"5510_CR2","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1517\/14656566.9.4.551","volume":"9","author":"R Pukkila-Worley","year":"2008","unstructured":"Pukkila-Worley R, Mylonakis E. Epidemiology and management of cryptococcal meningitis: developments and challenges. Expert Opin Pharmacother. 2008;9:551\u201360. https:\/\/doi.org\/10.1517\/14656566.9.4.551.","journal-title":"Expert Opin Pharmacother"},{"key":"5510_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3390\/jof5030071","volume":"124","author":"PG Pappas","year":"2013","unstructured":"Pappas PG. Cryptococcal infections in non-HIV-infected patients. Trans Am Clin Climatol Assoc. 2013;124:61\u201379. https:\/\/doi.org\/10.3390\/jof5030071.","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"5510_CR4","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1468-1331.2004.00856.x","volume":"11","author":"P Portegies","year":"2004","unstructured":"Portegies P, Solod L, Cinque P, Chaudhuri A, Begovac J, Everall I, et al. Guidelines for the diagnosis and management of neurological complications of HIV infection. Eur J Neurol. 2004;11:297\u2013304. https:\/\/doi.org\/10.1111\/j.1468-1331.2004.00856.x.","journal-title":"Eur J Neurol"},{"key":"5510_CR5","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1086\/649858","volume":"50","author":"JR Perfect","year":"2010","unstructured":"Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2010;50:291\u2013322. https:\/\/doi.org\/10.1086\/649858.","journal-title":"Clin Infect Dis"},{"key":"5510_CR6","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1016\/S0140-6736(04)16301-0","volume":"363","author":"AE Brouwer","year":"2004","unstructured":"Brouwer AE, Rajanuwong A, Chierakul W, Griffin GE, Larsen RA, White NJ, et al. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial. Lancet. 2004;363:1764\u20137. https:\/\/doi.org\/10.1016\/S0140-6736(04)16301-0.","journal-title":"Lancet."},{"key":"5510_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrneurol.2016.167","volume":"13","author":"PR Williamson","year":"2017","unstructured":"Williamson PR, Jarvis JN, Panackal AA, Fisher MC, Molloy SF, Loyse A, et al. Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy. Nat Rev Neurol. 2017;13:13\u201324. https:\/\/doi.org\/10.1038\/nrneurol.2016.167.","journal-title":"Nat Rev Neurol"},{"key":"5510_CR8","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1080\/01616412.2018.1447319","volume":"40","author":"L Xu","year":"2018","unstructured":"Xu L, Liu J, Zhang Q, Li M, Liao J, Kuang W, et al. Triple therapy versus amphotericin B plus flucytosine for the treatment of non-HIV- and non-transplant-associated cryptococcal meningitis: retrospective cohort study. Neurol Res. 2018;40:398\u2013404. https:\/\/doi.org\/10.1080\/01616412.2018.1447319.","journal-title":"Neurol Res"},{"key":"5510_CR9","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12883-018-1053-0","volume":"18","author":"J Liu","year":"2018","unstructured":"Liu J, Chen Z, Li M, Chen C, Yi H, Xu L, et al. Ventriculoperitoneal shunts in non-HIV cryptococcal meningitis. BMC Neurol. 2018;18:58. https:\/\/doi.org\/10.1186\/s12883-018-1053-0.","journal-title":"BMC Neurol"},{"key":"5510_CR10","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.bjid.2012.10.020","volume":"17","author":"JE Vidal","year":"2013","unstructured":"Vidal JE, Penalva de Oliveira AC, Dauar RF, Boulware DR. Strategies to reduce mortality and morbidity due to AIDS-related cryptococcal meningitis in Latin America. Braz J Infect Dis. 2013;17:353\u201362. https:\/\/doi.org\/10.1016\/j.bjid.2012.10.020.","journal-title":"Braz J Infect Dis"},{"key":"5510_CR11","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1136\/bmj.1.4550.582","volume":"1","author":"British Medical Research Council","year":"1948","unstructured":"British Medical Research Council. Streptomycin treatment of tuberculous meningitis. BMJ. 1948;1:582\u201397.","journal-title":"BMJ."},{"key":"5510_CR12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1055\/s-0034-1372342","volume":"34","author":"TM Azure","year":"2014","unstructured":"Azure TM, Grace MHG. New approaches to the diagnosis and treatment of cryptococcal meningitis. Semin Neurol. 2014;34:47\u201360. https:\/\/doi.org\/10.1055\/s-0034-1372342.","journal-title":"Semin Neurol"},{"key":"5510_CR13","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1086\/515110","volume":"28","author":"MS Saag","year":"1999","unstructured":"Saag MS, Cloud GA, Graybill JR, Sobel JD, Tuazon CU, Johnson PC, et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. Clin Infect Dis. 1999;28:291\u20136. https:\/\/doi.org\/10.1086\/515110.","journal-title":"Clin Infect Dis"},{"key":"5510_CR14","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1097\/00002030-200402200-00024","volume":"18","author":"F Dromer","year":"2004","unstructured":"Dromer F, Mathoulin-P\u00e9lissier S, Fontanet A, Ronin O, Dupont B, Lortholary O, et al. Epidemiology of HIV-associated cryptococcosis in France (1985-2001). AIDS. 2004;18:555\u201362. https:\/\/doi.org\/10.1097\/00002030-200402200-00024.","journal-title":"AIDS."},{"key":"5510_CR15","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1086\/590566","volume":"47","author":"BH Segal","year":"2008","unstructured":"Segal BH, Herbrecht R, Stevens DA, Ostrosky-Zeichner L, Sobel J, Viscoli C, et al. Defining response to therapy and study outcomes in clinical trials of invasive fungal disease: mycoses study group and European Organization for Research and Treatment of Cancer consensus criteria. Clin Infect Dis. 2008;47:674\u201383. https:\/\/doi.org\/10.1086\/590566.","journal-title":"Clin Infect Dis"},{"key":"5510_CR16","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3109\/13693780903437876","volume":"48","author":"LP Zhu","year":"2010","unstructured":"Zhu LP, Wu JQ, Xu B, Ou XT, Zhang QQ, Weng XH. Cryptococcal meningitis in non-HIV-infected patients in a Chinese tertiary care hospital, 1997-2007. Med Mycol. 2010;48:570\u20139. https:\/\/doi.org\/10.3109\/13693780903437876.","journal-title":"Med Mycol"},{"key":"5510_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0174459","volume":"12","author":"F Concha-Velasco","year":"2017","unstructured":"Concha-Velasco F, Gonz\u00e1lez-Lagos E, Seas C, Bustamante B. Factors associated with early mycological clearance in HIV-associated cryptococcal meningitis. PLoS One. 2017;12:e0174459. https:\/\/doi.org\/10.1371\/journal.pone.0174459.","journal-title":"PLoS One"},{"key":"5510_CR18","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1128\/AAC.48.3.985-991.2004","volume":"48","author":"RA Larsen","year":"2004","unstructured":"Larsen RA, Bauer M, Thomas AM, Graybill JR. Amphotericin B and fluconazole, a potent combination therapy for cryptococcal meningitis. Antimicrob Agents Chemother. 2004;48:985\u201391. https:\/\/doi.org\/10.1128\/AAC.48.3.985-991.2004.","journal-title":"Antimicrob Agents Chemother"},{"key":"5510_CR19","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1086\/599112","volume":"48","author":"PG Pappas","year":"2009","unstructured":"Pappas PG, Chetchotisakd P, Larsen RA, Manosuthi W, Morris MI, Anekthananon T, et al. A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis. Clin Infect Dis. 2009;48:1775\u201383. https:\/\/doi.org\/10.1086\/599112.","journal-title":"Clin Infect Dis"},{"key":"5510_CR20","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1086\/649861","volume":"50","author":"JC Nussbaum","year":"2010","unstructured":"Nussbaum JC, Jackson A, Namarika D, Phulusa J, Kenala J, Kanyemba C, et al. Combination flucytosine and high - dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi. Clin Infect Dis. 2010;50:338\u201344. https:\/\/doi.org\/10.1086\/649861.","journal-title":"Clin Infect Dis"},{"key":"5510_CR21","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.surneu.2005.04.037","volume":"64","author":"M Husain","year":"2005","unstructured":"Husain M, Jha DK, Rastogi M. Angiographic catheter: unique tool for neuroendoscopic surgery. Surg Neurol. 2005;64:546\u20139. https:\/\/doi.org\/10.1016\/j.surneu.2005.04.037.","journal-title":"Surg Neurol"},{"key":"5510_CR22","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.surneu.2005.01.023","volume":"64","author":"T Iwashita","year":"2005","unstructured":"Iwashita T, Kitazawa K, Koyama J, Nagashima H, Koyama T, Tanaka Y, et al. A saccular-like dissecting aneurysm of the anterior cerebral artery that developed 2 years after an ischemic event. Surg Neurol. 2005;64:538\u201341. https:\/\/doi.org\/10.1016\/j.surneu.2005.01.023.","journal-title":"Surg Neurol"},{"key":"5510_CR23","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1086\/427222","volume":"40","author":"PG Pappas","year":"2005","unstructured":"Pappas PG. Management cryptococcal meningitis is about handling the pressure. Clin Infect Dis. 2005;40:480\u20132. https:\/\/doi.org\/10.1086\/427222.","journal-title":"Clin Infect Dis"},{"key":"5510_CR24","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1097\/QAD.0b013e32832605fe","volume":"23","author":"T Bicanic","year":"2009","unstructured":"Bicanic T, Brouwer AE, Meintjes G, Rebe K, Limmathurotsakul D, Chierakul W, et al. Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures. AIDS. 2009;23:701\u20136. https:\/\/doi.org\/10.1097\/QAD.0b013e32832605fe.","journal-title":"AIDS."},{"key":"5510_CR25","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1093\/cid\/cit794","volume":"58","author":"JN Jarvis","year":"2014","unstructured":"Jarvis JN, Bicanic T, Loyse A, Namarika D, Jackson A, Nussbaum JC, et al. Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes. Clin Infect Dis. 2014;58:736\u201345. https:\/\/doi.org\/10.1093\/cid\/cit794.","journal-title":"Clin Infect Dis"},{"key":"5510_CR26","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1086\/515074","volume":"28","author":"PA Robinson","year":"1999","unstructured":"Robinson PA, Bauer M, Leal MA, Evans SG, Holtom PD, Diamond DA, et al. Early mycological treatment failure in AIDS-associated cryptococcal meningitis. Clin Infect Dis. 1999;28:82\u201392. https:\/\/doi.org\/10.1086\/515074.","journal-title":"Clin Infect Dis"},{"key":"5510_CR27","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.jmii.2017.06.002","volume":"51","author":"CW Hung","year":"2018","unstructured":"Hung CW, Lin WC, Chang WN, Su TM, Kung CT, Tsai NW, et al. Risk factors and outcomes of cerebrospinal fluid overdrainage in HIV-negativepatients with cryptococcal meningitis after the ventriculoperitoneal shunting procedure. J Microbiol Immunol Infect. 2018;51:545\u201351. https:\/\/doi.org\/10.1016\/j.jmii.2017.06.002.","journal-title":"J Microbiol Immunol Infect"},{"key":"5510_CR28","doi-asserted-by":"publisher","first-page":"ofz241","DOI":"10.1093\/ofid\/ofz241","volume":"6","author":"JW Baddley","year":"2019","unstructured":"Baddley JW, Thompson GR 3rd, Riley KO, Moore MK, Moser SA, Pappas PG. Factors\u2002Associated\u2002With\u2002Ventriculoperitoneal Shunt\u2002Placement\u2002in\u2002Patients\u2002With\u2002Cryptococcal Meningitis. Open Forum Infect Dis. 2019;6:ofz241. https:\/\/doi.org\/10.1093\/ofid\/ofz241 eCollection.","journal-title":"Open Forum Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05510-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-020-05510-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05510-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T05:07:30Z","timestamp":1605503250000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05510-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,16]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5510"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05510-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-26178\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-26178\/v4","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-26178\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-26178\/v3","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,16]]},"assertion":[{"value":"28 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committees of The Third Affiliated Hospital of Sun Yat-Sen University. The study was in compliance with the Declaration of Helsinki and its later amendments. All study participants provided written informed consent. Identifiable data involving the individuals in this study was encrypted.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"844"}}